Also listed on Sygnature Discovery Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Oct 20, 2036 · Low confidence
20-year base term ends Oct 20, 2036
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Oct 20, 2016
Oct 20, 2036
Mar 26, 2024
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 20, 2016, when application PCT/IB2016/001507, the earliest non-provisional in its chain, was filed (this one was filed Apr 7, 2021); a parent in its chain could not be resolved (the next row) | Oct 20, 2036 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Oct 20, 2036 | Low confidence |
Partial family
| Application PCT/IB2016/001507 | PCT application no patent term | no patent term |
| US 10,457,669 | In force Oct 2036 | Oct 2036 |
| US 11,001,575 | In force Oct 2036 | Oct 2036 |
| US 11,939,321 | this patent no later than Oct 2036 | no later than Oct 2036 |
| US 12,655,137 | In force Nov 2037 | Nov 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 7, 2021 Reel 55856, frame 25 | Astex Therapeutics Limited | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Apr 7, 2021 Reel 55856, frame 68 | Cooke, Michael Liam; Cousin, David; Onions, Stuart Thomas; Shannon, Jonathan Martin; Watts, John Paul | Sygnature Discovery Limited | Assignment of Assignor's Interest |
| Apr 8, 2021 Reel 55861, frame 79 | Berdini, Valerio; Buck, Ildiko Maria; Day, James Edward Harvey; Griffiths-jones, Charlotte Mary; Heightman, Thomas Daniel; Howard, Steven; Murray, Christopher William; Norton, David; O'reilly, Marc; Woolford, Alison Jo-anne | Astex Therapeutics Limited | Assignment of Assignor's Interest |
| Apr 8, 2021 Reel 55861, frame 86 | Sygnature Discovery Limited | Astex Therapeutics Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Oct 20, 2036. We will not guess the cap.